The profitability of Vaxcyte, Inc. over the past 8 years
Chart Vaxcyte, Inc.: operating income, net income, fiscal 2018–2025 Open the chart →Vaxcyte, Inc. reported a net loss of $766.63M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $923.67M. It reported a loss in all 8 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$923.67M | -$766.63M |
| 2024ended Dec 31, 2024 | -$569.55M | -$463.93M |
| 2023ended Dec 31, 2023 | -$468.04M | -$402.27M |
| 2022ended Dec 31, 2022 | -$232.26M | -$223.49M |
| 2021ended Dec 31, 2021 | -$103.67M | -$100.08M |
| 2020ended Dec 31, 2020 | -$89.58M | -$89.22M |
| 2019ended Dec 31, 2019 | -$54.15M | -$50.27M |
| 2018ended Dec 31, 2018 | -$35.53M | -$29.48M |
Fiscal years as Vaxcyte, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Vaxcyte, Inc.
Companies of a similar size
- TWSTTwist Bioscience Corporation
- ZETAZeta Global Holdings Corp.
- HQYHEALTHEQUITY, INC.
- REXRRexford Industrial Realty, Inc.
- FLSFLOWSERVE CORP
Not investment advice. This page shows what Vaxcyte, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.